Business · 01/03/2002Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for HECTOROL Patent Extension
Summary
The Food and Drug Administration has officially confirmed the review period for HECTOROL's patent extension application, as mandated by law, following a submission to the US Patent and Trademark Office.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →